ERBB2 and cirrhosis of liver: Since our study focused on the prognosis of HCC, controls such as healthy controls, chronic viral hepatitis B, or liver cirrhosis were not included, and the predictive performance of our marker using ERBB2, NRG4, and MIG6 for the diagnosis of HCC could not be confirmed.